Organization
Fort Wayne Medical Oncology and Hematology
1 abstract
Abstract
VELOCITY-Lung substudy-03: A phase 2 study of neoadjuvant domvanalimab (dom)+zimberelimab (zim)+chemotherapy (chemo) or zim+chemo followed by adjuvant dom+zim or zim in patients with resectable stage II-III non-small cell lung cancer (NSCLC).Org: Fort Wayne Medical Oncology and Hematology, Christian Hospital, University Hospitals Birmingham NHS Foundation Trust, Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS), Shaare Zedek Medical Center,